Saccomano Nicholas A
President and CEO at OKUR; CSO at ARRAY BIOPHARMA INC
- Sold, on record
- $4M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Sep 21, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- OKUROnKure Therapeutics, Inc.President and CEO
- ARRAY BIOPHARMA INCCSO
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ARRAY BIOPHARMA INC187,264 shares
- OKUR1,396 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ARRAY BIOPHARMA INCUnusualFeb 7, 2019 2019
Sold 187,264 shares at $21.58 ($4M)
Saccomano Nicholas A, CSO
Sold 56.8% of holdings ($7.1M position)142,488 shares leftFirst sale on recordFiling
- 2 Form 4 sale OKURNo planApr 7, 2025 +2251 days
Sold 874 shares at $2.94 ($3k)
Saccomano Nicholas A, President and CEO
No 10b5-1 planSold 19.2% of holdings ($13k position)3,682 shares leftFirst sale on recordFiling
- 3 Form 4 sale OKURNo planJun 23, 2025 +77 days
Sold 88 shares at $2.38 ($209)
Saccomano Nicholas A, President and CEO
No 10b5-1 planSold 2.4% of holdings ($9k position)3,594 shares leftFiling
- 4 Form 4 sale OKURNo planSep 22, 2025 +91 days
Sold 88 shares at $2.62 ($231)
Saccomano Nicholas A, President and CEO
No 10b5-1 planSold 2.4% of holdings ($9k position)3,506 shares leftFiling
- 5 Form 4 sale OKURNo planDec 22, 2025 +91 days
Sold 87 shares at $2.97 ($258)
Saccomano Nicholas A, President and CEO
No 10b5-1 planSold 1.2% of holdings ($22k position)7,419 shares left1x usual sizeFiling
- 6 Form 4 sale OKURNo planMar 23, 2026 +91 days
Sold 86 shares at $4.16 ($358)
Saccomano Nicholas A, President and CEO
No 10b5-1 planSold 1.2% of holdings ($31k position)7,333 shares left1x usual sizeFiling
- 7 Form 4 sale OKURNo planJun 22, 2026 +91 days
Sold 86 shares at $4.40 ($378)
Saccomano Nicholas A, President and CEO
No 10b5-1 planSold 0.8% of holdings ($50k position)11,247 shares left1x usual sizeFiling
- 8 Form 4 sale OKURNo planSep 21, 2026 +91 days
Sold 87 shares at $2.97 ($258)
Saccomano Nicholas A, President and CEO
No 10b5-1 planSold 0.8% of holdings ($33k position)11,160 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Sep 23, 2026 | OKUR | President and CEO | Form 4 sale | 87 | $258 | 0.8% | No plan | SEC |
| Jun 22, 2026 | Jun 24, 2026 | OKUR | President and CEO | Form 4 sale | 86 | $378 | 0.8% | No plan | SEC |
| Mar 23, 2026 | Mar 24, 2026 | OKUR | President and CEO | Form 4 sale | 86 | $358 | 1.2% | No plan | SEC |
| Dec 22, 2025 | Dec 23, 2025 | OKUR | President and CEO | Form 4 sale | 87 | $258 | 1.2% | No plan | SEC |
| Sep 22, 2025 | Sep 24, 2025 | OKUR | President and CEO | Form 4 sale | 88 | $231 | 2.4% | No plan | SEC |
| Jun 23, 2025 | Jun 25, 2025 | OKUR | President and CEO | Form 4 sale | 88 | $209 | 2.4% | No plan | SEC |
| Apr 7, 2025 | Apr 8, 2025 | OKUR | President and CEO | Form 4 sale | 874 | $3k | 19.2% | No plan | SEC |
| Feb 7, 2019 | Feb 8, 2019 | ARRAY BIOPHARMA INC | CSO | Form 4 sale | 187,264 | $4M | 56.8% | Unusual | SEC |